Pinkse et al. [84] focused on administering immunodominant peptides derived from major antigens to down-regulate cytotoxic CD8+ T cells associated with β cell destruction in type 1 diabetes. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.